Smart surgery plays a lead role in the new era of intelligent medical technology. It provides surgeons with real-time information to improve decision-making in the operating room and offers benefits across the care continuum. Figure 1 outlines key enabling technologies that are powering
the smart surgery revolution.
Label-free sensing technologies have much potential to drive progress in smart surgery, especially in the field of oncology surgery. Marker free imaging technologies avoid the need to tag tumours using markers, which is beneficial because it avoids the regulatory and clinical burden of introducing new markers to the market.
Sagentia Medical’s Applied Science Team explore the potential role of label-free sensing in the smart surgery phenomenon. Exempt from the regulatory and clinical burdens affecting biomarkers, these technologies could unlock new possibilities for oncology surgery.

This white paper discusses:
- Oncology surgery
- Raman Spectroscopy
- Tissue autofluorescence spectroscopy
- Mass spectrometry
Read more of our insights
June 20, 2025
Closing the Alzheimer’s gender gap: innovating around early diagnosis and treatment
April 24, 2025
Overcoming technical barriers to blood-based diagnosis of neurodegenerative disease
February 13, 2025
Five critical factors for the commercialisation of women’s health technology